Antibody Library Technology Market to Reach US$ 246.5 Million at 4% CAGR by 2034, States Fact.MR

Need to Combat Rising Prevalence of Chronic Diseases Driving Demand for Antibody Library Technology Solutions

Rockville, Dec. 04, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global Antibody Library Technology Market is estimated at US$ 165.8 million in 2024 and is projected to expand at a CAGR of 4% from 2024 to 2034. Antibody library technologies are methods for producing diverse antibody collections for use in research, diagnostics, and therapy. These methods enable the creation and testing of antibodies with desirable properties, such as high affinity and specificity for a target molecule.

Antibody libraries can be created intentionally by dynamically assembling antibody fragment sequences to provide a large range of antibody variants, or they can be collected naturally from sources such as human or animal immune systems. Scientists can uncover antibodies with the correct binding qualities and potential uses in medicine by screening these libraries specifically.

For More Insights into the Market, Request a Sample of this Report:

Key Segments of Antibody Library Technology Industry Research Report

By TechnologyBy ApplicationBy End UserBy Region
  • Phage Display
  • Ribosome Display
  • Yeast Display
  • Mammalian Cell Display
  • Research Applications
  • Drug Discovery & Development
  • Others
  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Others
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA

The ability to produce and select antibodies with high specificity and affinity for a wide range of targets, including proteins, peptides, small molecules, and even complex cellular structures, has fundamentally altered the field of antibody discovery and development.

Key Takeaways from Market Study

  • The global antibody library technology market is estimated at a valuation of US$ 165.8 million in 2024.
  • The market is forecasted to reach US$ 246.5 million by 2034-end.
  • Demand for antibody library technology is projected to rise at a CAGR of 4% from 2024 to 2034.
  • The market in East Asia is predicted to expand at 4.9% CAGR over the next 10 years.
  • The phage display segment is predicted to hold 54.9% market share in 2024.
  • Based on applications, drug discovery & development is projected to account for 62.8% market share in 2024.
  • North America is set to account for 59.9% of the global market share in 2024.

“Owing to the rising incidence of chronic diseases, there is an increased demand for focused therapy, and antibody library technologies are increasingly being employed to generate new medications to treat these diseases,” says Fact.MR analyst.

Increasing Emphasis on Personalized Medicine

Personalized medicine is a particularly unique and fascinating topic in the medical and healthcare industries at the moment. It is a notion that has the potential to alter medical treatments by offering effective, customized therapeutic solutions based on the genetic, epigenomic, and proteomic profile of the individual.

Personalized medicine is the practice of tailoring a therapy that is as unique as the condition. Based on the identification of genetic, epigenomic, and clinical data, the approach helps a physician gain a better knowledge of how an individual's distinct genomic profile predisposes them to particular diseases. Personalized medicine is a thorough expansion of the traditional (one-size-fits-all) approach to increasing the capacity of healthcare professionals to forecast which medical therapies would be safe and useful for individual patients based on the patient's unique genetic profile.

In the healthcare industry, personalized medicine is a novel but swiftly evolving segment in which a healthcare provider can select a treatment based on the genetic profile of the patient, potentially reducing undesirable side effects while simultaneously ensuring a more effective outcome. A higher degree of patient classification facilitates efficient application of proactive treatment plans and individualized medicine, which is projected to cut costs and enhance quality of life.

Get Customization on this Report for Specific Research Solutions:

Report AttributeDetails
Value Projection (2034)USD 246.5 Million
Growth Rate (2024-2034)4% CAGR
No. of pages170 Pages
No. of Tables84 Tables
No. of Figures112 Figures

More Valuable Insights
on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the antibody library technology market for 2018 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on technology (phage display, ribosome display, yeast display, mammalian cell display), application  (research applications, drug discovery & development, others), and end user (biopharmaceutical companies, academic & research institutes, contract research organizations, others), across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and MEA).

Checkout More Related Studies Published by Fact.MR Research:

Antibody Contract Manufacturing Market: The global antibody contract manufacturing market size is calculated at a size of US$ 6.1 billion for 2024 and is forecasted to reach US$ 20.85 billion by the end of 2034, expanding at a double-digit CAGR of 13.1%.

Antibody Drug Conjugates Contract Market: The global antibody drug conjugate contract market demand is anticipated to be valued at US$ 9.2 Billion in 2022, forecast a CAGR of 15.5% to be valued at US$ 38.8 Billion from 2022 to 2032.

Antibodies Market: The global antibodies market size is valued at US$ 197.3 billion and is projected to exhibit expansion at a stellar CAGR of 11.9% over the next ten years. The market is anticipated to bloat 3X to surpass a valuation of US$ 608 billion by the end of 2032.

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter | Blog